HIGHLIGHTS
- who: Miklu00f3s Fagyas from the Department of Internal Medicine, Faculty of Medicine, University of have published the research: The majority of severe COVID-19 patients develop anti-cardiac autoantibodies, in the Journal: (JOURNAL)
- what: The authors aimed to detect anti-cardiac autoantibodies in severe COVID-19 patients during hospitalization. In the light of the findings of this study, the authors propose that anti-cardiac autoantibodies may contribute to cardiac complications in long COVID, or PASC.
- how: The authors hypothesized that a subset of and contributed equally to the study. In this study 104 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.